FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
NEW YORK, May 26 (Reuters) - Allergan Inc said on Tuesday that U.S. health regulators will require more information before approving its Botox anti-wrinkle drug as a treatment for upper limb ...
Henry Winkler, known for his television role as Arthur "The Fonz" Fonzarelli, made it a happy day for many people in the Triangle Tuesday who suffer from upper limb spasticity. Henry Winkler, known ...
Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...
CHICAGO/WASHINGTON, Sept 1 (Reuters) - Allergan Inc has agreed to plead guilty and pay $600 million to resolve a federal probe of its marketing practices for the injectable wrinkle smoother Botox, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback